BATF promotes lipolysis and energy consumption in hepatocytes by regulating PD1 transcription, thereby reducing HFD-induced liver lipid deposition and alleviating NAFLD (Figure 5H). The gene discussed is BATF; the disease is metabolic dysfunction-associated steatotic liver disease.